GNPX
Price:
$0.6402
Market Cap:
$1.04M
Genprex, Inc. is a biotechnology firm specializing in gene therapy, with its primary focus on advancing treatments through clinical stages. Their mission revolves around developing innovative therapies for patients battling cancer and diabetes. Leading their product pipeline is REQORSA (GPX-001), a flagship gene therapy candidate specifically designed to target both non-small cell lung cancer and small cell lung cancer. In addition, Genprex is progressing GPX-002, another gene therapy at the preclinical stage, intended for the management of diabetes. The company was established in 2009 and operates from its corporate headquarters located in Austin, Texas.
Industry
Biotechnology
IPO Date
2018-03-29
Stock Exchange
NASDAQ
Ticker
GNPX
According to Genprex, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -17004550.00. This represents a change of 4.82% compared to the average of -345500.19 of the last 4 quarters.
The mean historical Enterprise Value of Genprex, Inc. over the last ten years is 30.60M. The current -17004550.00 Enterprise Value has changed -5656.79% with respect to the historical average. Over the past ten years (40 quarters), GNPX's Enterprise Value was at its highest in in the March 2021 quarter at 149.12M. The Enterprise Value was at its lowest in in the December 2025 quarter at -6198577.50.
Average
30.60M
Median
14.84M
Minimum
-6198577.50
Maximum
120.09M
Discovering the peaks and valleys of Genprex, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.75%
Maximum Annual Enterprise Value = 120.09M
Minimum Annual Increase = -442.50%
Minimum Annual Enterprise Value = -6198577.50
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | -6198577.50 | -442.50% |
| 2024 | 1.81M | -69.00% |
| 2023 | 5.84M | -87.97% |
| 2022 | 48.53M | 110.58% |
| 2021 | 23.05M | -80.81% |
| 2020 | 120.09M | 3.75% |
| 2019 | 3.12M | -52.96% |
| 2018 | 6.63M | -87.73% |
| 2017 | 54.00M | 9.84% |
| 2016 | 49.16M | 484.25% |
The current Enterprise Value of Genprex, Inc. (GNPX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
483.33K
5-year avg
14.61M
10-year avg
30.60M
Genprex, Inc.’s Enterprise Value is less than InMed Pharmaceuticals Inc. (-2005797.00), less than Liminatus Pharma, Inc. Class A Common Stock (2.81M), less than Biodexa Pharmaceuticals Plc (-6776175.05), less than CERo Therapeutics Holdings, Inc. (-245885.00), less than Jaguar Health, Inc. (27.21M), less than GRI Bio, Inc. (-10787878.00), less than BioVie Inc. (-510061.00), less than CNS Pharmaceuticals, Inc. (91.17K), less than Theriva Biologics, Inc. (-1521880.00), less than Chemomab Therapeutics Ltd. (4.25M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| -2005797.00 | $2.73M | |
| 2.81M | $3.27M | |
| -6776175.05 | $2.26M | |
| -245885.00 | $13.26K | |
| 27.21M | $179.26K | |
| -10787878.00 | $202.12K | |
| -510061.00 | $12.29M | |
| 91.17K | $2.81M | |
| -1521880.00 | $10.84M | |
| 4.25M | $10.16M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genprex, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Genprex, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Genprex, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Genprex, Inc. (GNPX)?
What is the 3-year average Enterprise Value for Genprex, Inc. (GNPX)?
What is the 5-year average Enterprise Value for Genprex, Inc. (GNPX)?
How does the current Enterprise Value for Genprex, Inc. (GNPX) compare to its historical average?